Industry perspectives on personalized medicine

Nature Reviews Drug Discovery

Volumn 11, Issue 3, 2012, Pages 178-

  Zuckerman, Rachael ^a   Milne, Christopher Paul ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

DRUG APPROVAL; DRUG RESEARCH; NOTE; PERSONALIZED MEDICINE; PHARMACOGENOMICS; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; ANIMAL; DRUG INDUSTRY; ECONOMICS; HEALTH CARE COST; HUMAN;

ANIMALS; DRUG INDUSTRY; HEALTH CARE SECTOR; HUMANS; INDIVIDUALIZED MEDICINE;

EID: 84857746354     PISSN: 14741776     EISSN: 14741784     Source Type: Journal    
DOI: 10.1038/nrd3677     Document Type: Note

References (0)